$CBDL entering into medical cannabis.
Medical cannabis works at surprisingly low blood levels!
15–30 ng/mL THC was associated with pain relief in diabetic nerve pain.
Levels under 20 ng/mL were linked to reduced eye pressure.
About 7.5–10 ng/mL improved tic symptoms.
For nabiximols: 1–10 ng/mL THC was identified as a preliminary range for nerve pain and muscle spasticity in multiple sclerosis.
For chemotherapy-related nausea:
Nabilone: roughly 1–5 ng/mL.
Dronabinol: roughly 5–15 ng/mL THC.
pubmed.ncbi.nlm.nih.gov/4226…
1
80
$CBDL helping with cancer
CBD is showing REAL power against deadly glioblastoma (brain cancer)!
CBD seems to fight brain tumors in several ways:
It messes with the signals that tell cancer cells to grow.
It slows down or stops the tumor cells from multiplying.
It can make regular chemotherapy drugs work better on the cancer.
pubmed.ncbi.nlm.nih.gov/4128…
114
$CBDL helping with women’s health
CBDA + CBD suppository cuts menstrual cramps by 44–68% !
Overall, average pain score dropped from 6.38 to 3.54 — a 44% reduction in pain.
Women who started with milder pain saw an even bigger improvement: from 5.43 down to 1.71 — a 68% reduction.
81% of the women ended up needing fewer oral painkillers.
academic.oup.com/jsm/article…
125
$CBDL helping the community
THC & CBD) show strong anti-tumor effects in pancreatic cancer!
They can trigger cancer cells to die (apoptosis)
They can stop cancer cells from multiplying (cell cycle arrest)
They can reduce the growth of new blood vessels that feed the tumor (anti-angiogenesis)
They can help adjust the body’s immune response around the tumor
They can lower harmful oxidative stress in cells.
ar.iiarjournals.org/content/…
Metastasis kills 90% of cancer patients. Cannabis compounds may help block it!
frontiersin.org/journals/onc…
1
188
$CBDL adding more to its pain line of products. Best on the market,
Medical Cannabis as an Opiate Alternative?
Opioid use dropped sharply in the first month — a 65% reduction and stayed lower through five months.
Average pain scores fell by about 2 points in the first month (from 7.0 to 5.1) and the improvement held at five months.
Patients reported better physical functioning that was also maintained at five months.
pubmed.ncbi.nlm.nih.gov/4215…
1
168
This study found 87.9% reported cannabis reduced their neuropathic pain!
In 2023, a study was released on the effects of cannabis and cannabinoids on neuropathic pain and pain medication use in people with spinal cord injury.
The results were astounding finding that “87.9% noted that cannabis reduced their neuropathic pain intensity by more than 30%, and 92.3% reported that cannabis helped them to better deal with their neuropathic pain symptoms.
Most participants (83.3%) also reported substituting their pain medications with cannabis, with the most substituted medication categories being opioids (47.0%), gabapentinoids (42.8%) and over-the-counter pain medications (42.2%).”
pubmed.ncbi.nlm.nih.gov/3818…
2
219
$CBDL helping the market
TEN Associates LLC retweeted
Labor markets continue to see gains, but is this yesterday’s news?
Today's nonfarm payroll figure came in stronger than expected at 165,000 jobs gained in October, with upward revisions of 84,000 for the prior two months. The unemployment rate remained fairly steady at 4.1%.
For some time, we've characterized the labor market as a period of "low hire/low fire" jobs growth, whereby firms are neither hiring many new workers nor laying many off. Indeed, average monthly jobs growth over the past 6- and 12-month periods has been 83,000 and 74,000, respectively. Today's stronger numbers are encouraging, but they need to be considered within the context of broader economic growth.
Interestingly, we find ourselves in an environment where economic growth and labor market gains appear to be decoupling in profound ways. Real GDP growth accelerated to 3.4% in the third quarter, yet labor market gains have been more modest over the last several months. An outsized portion of the growth we're witnessing derives from capital expenditure related to the AI infrastructure buildout. Consider that investment in computers and peripheral equipment, representing just 2% of overall GDP, accounted for more than a third of GDP growth over the last 12 months.
From a monetary policy standpoint, as long as we remain in this solid economic environment, with inflation running well above the Fed's 2% target, labor markets are unlikely to be top of mind for policymakers. Meanwhile, the profound AI investment cycle continues to drive broad economic and corporate earnings growth. Yet an increasingly concentrated group of companies is creating and capturing an outsized share of the benefits, leaving the broader equity market highly sensitive to changes in just a handful of names. In recent days, we've begun to see greater equity market volatility amid concerns over potential future regulation.
Today's payroll data was interesting and confirmatory of an economy that has been operating at a breathtakingly strong pace. But it's also a comprehensive read on labor relative to yesterday's economic conditions. Markets today are much more focused on the future of AI spending, capital allocation and rebalancing activity, as well as how a new political framework will influence growth, fiscal conditions and the operating environment for different industries.
How, then, should one position fixed income portfolios? In our view, the regime has shifted and fixed income yields reside at historically attractive levels. Real rates are positive across the globe, while the equity risk premium remains paper-thin and equity market concentration creates fragility and volatility that investors don't need to accept. We think a diversified, income-oriented portfolio can deliver equity-like returns today with dramatically less volatility, drawdown and concentration risk. Recent market activity seems to reinforce that view and we think that should continue well into 2027.
$CBDL helps with autism
Out today!
CBD may be changing how autistic kids’ brains connect!
Daily marijuana use had ~39% lower odds glaucoma than non-users!
CBD cut this girl’s seizures from 30 a day to one every three days!
And more! Stay tuned!
1
151
$CBDL has product to help lower blood pressure. Full spectrum CBD.
CBD may lower blood pressure, protect blood vessels, and reduce inflammation!
Studies suggest CBD can lower blood pressure, improve how blood vessels function, and reduce certain stress-related peptides!
Current evidence indicates CBD has promising anti-inflammatory, antioxidant, and vessel-protective effects that could support heart-disease treatment.
pubmed.ncbi.nlm.nih.gov/4109…
1
191
Cannabinoids may help limit heart scarring after a heart attack!
Activating the cannabinoid type 2 (CB2) receptor looks especially promising for reducing fibrosis.
Blocking the cannabinoid type 1 (CB1) receptor in the periphery (outside the brain) also appears helpful.
The protective effects seem to come mainly from their ability to lower inflammation and oxidative stress, which in turn limits scar formation and helps restore more normal signaling in the heart.
pubmed.ncbi.nlm.nih.gov/4166…
140
TEN Associates LLC retweeted
Replying to @TenAssocLLC
Shareholders… we hear you. $BFCH.
newmediawire.com/news/bfch-p…
$CBDL helping this market
New study: Hemp seed protein dropped 24-hour blood pressure!
Compared with the milk protein, the hemp protein + peptides version lowered 24-hour blood pressure the most.
Plain hemp seed protein also lowered blood pressure compared with milk protein, but not as much.
Both hemp versions improved blood markers linked to blood pressure better than milk protein did: they reduced ACE and renin activity (factors that can raise blood pressure) and increased nitric oxide (which helps relax blood vessels).
pubmed.ncbi.nlm.nih.gov/3871…
1
202
164

















